Concepedia

Ricardo Miguel Costa de Freitas

RM

Statistics

Publications

13

Citations

496

H-Index

12

Active since

1996

Affiliations

Instituto do Câncer do Estado de São Paulo(Current)

Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo

Universidade de São Paulo

Universidade Federal de Minas Gerais

Universidade do Porto

Ricardo Miguel Costa de Freitas is an author at Instituto do Câncer do Estado de São Paulo specializing in medicine, pathology, and radiology.

ORCID

Top concepts

Publications per year

1996–2020

13

Publications

13

On the role of subtype selective adenosine receptor agonists during proliferation and osteogenic differentiation of human primary bone marrow stromal cells

Maria Adelina Costa, António Daniel Barbosa, Estrela Neto et al. · Journal of Cellular Physiology · 2010 · 137 citations

Role of ecto‐NTPDases on UDP‐sensitive P2Y<sub>6</sub>receptor activation during osteogenic differentiation of primary bone marrow stromal cells from postmenopausal women

José Bernardo Noronha‐Matos, Maria Adelina Costa, M.T. Magalhães‐Cardoso et al. · Journal of Cellular Physiology · 2011 · 71 citations

Comparison of 68Ga PET/CT to Other Imaging Studies in Medullary Thyroid Cancer: Superiority in Detecting Bone Metastases

Luciana Audi Castroneves, George Barbério Coura-Filho, Ricardo Miguel Costa de Freitas et al. · The Journal of Clinical Endocrinology & Metabolism · 2018 · 47 citations · Full text

Sorafenib for the Treatment of Progressive Metastatic Medullary Thyroid Cancer: Efficacy and Safety Analysis

Luciana Audi Castroneves, Marcelo V. Negrão, Ricardo Miguel Costa de Freitas et al. · Thyroid · 2015 · 44 citations

Potential role of sorafenib as neoadjuvant therapy in unresectable papillary thyroid cancer

Debora Lúcia Seguro Danilovic, Gilberto de Castro, Felipe Roitberg et al. · Archives of Endocrinology and Metabolism · 2018 · 37 citations · Full text

, , +17

1–5 of 13